93 related articles for article (PubMed ID: 38491510)
1. Complex immune microenvironment of chordoma: a road map for future treatment.
Niu HQ; Zheng BY; Zou MX; Zheng BW
J Immunother Cancer; 2024 Jun; 12(6):. PubMed ID: 38908855
[TBL] [Abstract][Full Text] [Related]
2. Reinvigorating exhausted CD8
Hossain MA; Liu G; Dai B; Si Y; Yang Q; Wazir J; Birnbaumer L; Yang Y
Med Res Rev; 2021 Jan; 41(1):156-201. PubMed ID: 32844499
[TBL] [Abstract][Full Text] [Related]
3. The immune landscape of esophageal cancer.
Huang TX; Fu L
Cancer Commun (Lond); 2019 Nov; 39(1):79. PubMed ID: 31771653
[TBL] [Abstract][Full Text] [Related]
4. Sex disparities revealed by single-cell and bulk sequencing and their impacts on the efficacy of immunotherapy in esophageal cancer.
Yan H; Huang J; Li Y; Zhao B
Biol Sex Differ; 2024 Mar; 15(1):22. PubMed ID: 38491510
[TBL] [Abstract][Full Text] [Related]
5. The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients.
Strizova Z; Snajdauf M; Stakheev D; Taborska P; Vachtenheim J; Biskup J; Lischke R; Bartunkova J; Smrz D
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1979-1992. PubMed ID: 32447483
[TBL] [Abstract][Full Text] [Related]
6. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
7. Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma.
Wen J; Fang S; Hu Y; Xi M; Weng Z; Pan C; Luo K; Ling Y; Lai R; Xie X; Lin X; Lin T; Chen J; Liu Q; Fu J; Yang H
EBioMedicine; 2022 Dec; 86():104371. PubMed ID: 36434949
[TBL] [Abstract][Full Text] [Related]
8. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
Jin R; Liu C; Zheng S; Wang X; Feng X; Li H; Sun N; He J
Cancer Biol Med; 2020 Aug; 17(3):768-781. PubMed ID: 32944405
[No Abstract] [Full Text] [Related]
9. Mechanisms and consequences of sex differences in immune responses.
Dunn SE; Perry WA; Klein SL
Nat Rev Nephrol; 2024 Jan; 20(1):37-55. PubMed ID: 37993681
[TBL] [Abstract][Full Text] [Related]
10. Targeting DNA Damage Repair and Immune Checkpoint Proteins for Optimizing the Treatment of Endometrial Cancer.
Bian X; Sun C; Cheng J; Hong B
Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765210
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in renal cell carcinoma: a single-cell analysis reveals exhausted CD8
Ning K; Peng Y; Jiang Y; Li Z; Luo X; Lin L; Deng M; Wu Y; Huang T; Huang Y; Xie Y; Yang X; Zhang M; Xiong L; Zou X; Zhou Z; Zhou F; Dong P; Yu C; Zhang Z
Biol Sex Differ; 2023 Sep; 14(1):58. PubMed ID: 37715192
[TBL] [Abstract][Full Text] [Related]
12. RAS signaling and immune cells: a sinister crosstalk in the tumor microenvironment.
Liu Y; Xie B; Chen Q
J Transl Med; 2023 Sep; 21(1):595. PubMed ID: 37670322
[TBL] [Abstract][Full Text] [Related]
13. Intermediate endpoints as surrogates for outcomes in cancer immunotherapy: a systematic review and meta-analysis of phase 3 trials.
Zhang Z; Pan Q; Lu M; Zhao B
EClinicalMedicine; 2023 Sep; 63():102156. PubMed ID: 37600482
[TBL] [Abstract][Full Text] [Related]
14. The landscape of T cell antigens for cancer immunotherapy.
Peri A; Salomon N; Wolf Y; Kreiter S; Diken M; Samuels Y
Nat Cancer; 2023 Jul; 4(7):937-954. PubMed ID: 37415076
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
